Mario Delgado
Mario Delgado
Instituto de Parasitologia y Biomedicina
Verified email at IPB.CSIC.ES
Title
Cited by
Cited by
Year
Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis
E Gonzalez-Rey, P Anderson, MA González, L Rico, D Büscher, ...
Gut 58 (7), 929-939, 2009
6692009
Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses
MA González, E Gonzalez–Rey, L Rico, D Büscher, M Delgado
Gastroenterology 136 (3), 978-989, 2009
6132009
Treatment of experimental arthritis by inducing immune tolerance with human adipose‐derived mesenchymal stem cells
MA González, E Gonzalez‐Rey, L Rico, D Büscher, M Delgado
Arthritis & Rheumatism: Official Journal of the American College of …, 2009
5362009
The significance of vasoactive intestinal peptide in immunomodulation
M Delgado, D Pozo, D Ganea
Pharmacological Reviews 56 (2), 249-290, 2004
4252004
Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease
M Delgado, C Abad, C Martinez, J Leceta, RP Gomariz
Nature medicine 7 (5), 563-568, 2001
3972001
Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis
E Gonzalez-Rey, MA Gonzalez, N Varela, F O’Valle, P Hernandez-Cortes, ...
Annals of the rheumatic diseases 69 (01), 241-248, 2010
3962010
Therapeutic action of ghrelin in a mouse model of colitis
E Gonzalez–Rey, A Chorny, M Delgado
Gastroenterology 130 (6), 1707-1720, 2006
2622006
Requirement of IFN-γ–mediated indoleamine 2, 3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose–derived stem cells
O DelaRosa, E Lombardo, A Beraza, P Mancheno-Corvo, C Ramirez, ...
Tissue Engineering Part A 15 (10), 2795-2806, 2009
2552009
Regulation of immune tolerance by anti-inflammatory neuropeptides
E Gonzalez-Rey, A Chorny, M Delgado
Nature Reviews Immunology 7 (1), 52-63, 2007
2472007
Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease
C Abad, C Martinez, MG Juarranz, A Arranz, J Leceta, M Delgado, ...
Gastroenterology 124 (4), 961-971, 2003
2462003
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies
M Delgado, EJ Munoz-Elias, RP Gomariz, D Ganea
The Journal of Immunology 162 (3), 1707-1716, 1999
2061999
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-α and IL-6
M Delgado, C Martinez, D Pozo, JR Calvo, J Leceta, D Ganea, ...
The Journal of Immunology 162 (2), 1200-1205, 1999
2011999
Immunology of VIP: a review and therapeutical perspectives
RP Gomariz, C Martinez, C Abad, J Leceta, M Delgado
Current pharmaceutical design 7 (2), 89-111, 2001
1892001
Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells
E Gonzalez-Rey, A Chorny, A Fernandez-Martin, D Ganea, M Delgado
Blood 107 (9), 3632-3638, 2006
1862006
VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNγ synthesis by T cells
M Delgado, EJ Munoz-Elias, RP Gomariz, D Ganea
Journal of neuroimmunology 96 (2), 167-181, 1999
1821999
Adipose-derived mesenchymal stromal cells induce immunomodulatory macrophages which protect from experimental colitis and sepsis
P Anderson, L Souza-Moreira, M Morell, M Caro, F O'Valle, ...
Gut 62 (8), 1131-1141, 2013
1772013
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-α production by macrophages: in vitro and in vivo studies
M Delgado, D Pozo, C Martinez, J Leceta, JR Calvo, D Ganea, ...
The Journal of Immunology 162 (4), 2358-2367, 1999
1761999
Neuroprotective effect of vasoactive intestinal peptide (VIP) in a mouse model of Parkinson's disease by blocking microglial activation
M Delgado, D Ganea
The FASEB journal 17 (8), 1-18, 2003
1752003
Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders
A Chorny, E Gonzalez-Rey, A Fernandez-Martin, D Pozo, D Ganea, ...
Proceedings of the National Academy of Sciences 102 (38), 13562-13567, 2005
1732005
Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases
M Delgado, C Abad, C Martinez, M Juarranz, A Arranz, R Gomariz, ...
Journal of molecular medicine 80 (1), 16-24, 2002
1732002
The system can't perform the operation now. Try again later.
Articles 1–20